Business

TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend

TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend.

articleBiostax Corp.September 29, 20144/company/biostax-corp/news/tni-biotech-inc-corporations-ceo-issues-letter-to-shareholders-discussing-cytocom-dividend
TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend

About this update from Biostax Corp.

[{"type":"text","content":"\n\n\n\nTNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend\nPR Newswire\nORLANDO, Fla. and DUBLIN, Sept. 29, 2014\n\n\n\nORLANDO, Fla. and DUBLIN, Sept. 29, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) (\"we\" or the \"Company\"), a biotechnology company pioneering the manufacturing both US and Internationally as well as the marketing of innovative therapies for cancer, HIV/AIDS, opportunistic infections and autoimmune diseases in emerging nations, issued a letter to its shareholders from CEO Noreen Griffin The letter follows:\n\nDear Shareholders,\n\nTNI BioTech, Inc. (the \"Company\" or \"TNIB\") received a number of calls from shareholders and wants to once again make the terms of the spin-off and Cytocom Inc. share divided clear to our shareholders.\n\nAlthough the record date for the spin-off is September 30, 2014, there is a grace period until the 30th of October 2014 to deliver all shares to the Company's transfer agent, Guardian Registrar & Transfer, Inc.  This is a mandatory delivery of all shares to our transfer agent by shareholders or their brokers to receive the Cytocom Inc. share divided.  The Spin out will not be completed before November 1, 2014, to provide time for the mandatory deliver of shares to the transfer agent. \n\nThe Company has announced the Cytocom divided and provided notice a number of times over the last two months.  The Depository Trust Corporation (\"DTC\") has worked with the Company to make the Cytocom Inc. share divided process as simple as possible for our shareholders and brokerage firms. Shares can be transferred electronically through the Deposit and Withdrawal at Custodian (\"DWAC\") service using a Fast Automated Securities Transfer Service (\"FAST\")\n\nThe Company's legal counsel received the below email from a broker and due to the nature of the email, and all of the people that were included on the email, and c...

More updates from Biostax Corp.